Anticoagulation is unnecessary after biological aortic valve replacement

Circulation

Volumn 98, Issue 19 SUPPL., 1998, Pages

  Moinuddeen, Khaja ^a   Quin, Jacquelyn ^a   Shaw, Richard ^a   Dewar, Michael ^a   Tellides, George ^a   Kopf, Gary ^a   Elefteriades, John ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulants; Embolism; Prosthesis; Stroke; Valves

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

AGED; ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; BRAIN ISCHEMIA; DRUG THERAPY, COMBINATION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UNNECESSARY PROCEDURES; WARFARIN;

EID: 0345451665     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Carpentier A, Lane E, Carpentier S, Deloche A, Chauvaud S, Maxwell S. Continuing improvements in valvular bioprosthesis. J Thorac Cardiovasc Surg. 1982;83:27-42.
2. Oyer PE, Stinson EB, Reitz BA, Miller DC, Rossiter SJ, Shummay NE. Long term evaluation of the porcine xenograft bioprosthesis. J Thorac Cardiovasc Surg. 1979;78:343-350.
3. Douglas PS, Hirshfield JW Jr, Edie RN, Harken AH, Stephenson LW, Edmunds LH. Clinical comparison of St Jude and porcine aortic valve prostheses. Circulation. 1985;72(suppl 2):II-135-II-139.
4. Fradet GJ, Jamieson WR, Abel JG, Lichtenstein SV, Miyagishima RT, Ling H, Tyers GF. Clinical performance of biological and mechanical prostheses. Ann Thorac Surg. 1995;60(2 suppl):453-458.
5. Jamieson WR, Hayden RI, Miyagishima RT, Tutassaure H, Munro AI, Gerein AN, Burr LH, MacNab J, Janusz MT, Chan F, Ling H, Tyers FO. The Carpentier-Edwards standard porcine bioprosthesis: clinical performance to 15 years. J Card Surg. 1991;6(suppl):550-556.
6. Hartz RS, Fisher EB, Finkelmeier B, DeBoer A, Sanders JH Jr, Moran JM, Michaelis LL. An eight-year experience with porcine bioprosthetic cardiac valves. J Thorac Cardiovasc Surg. 1986;91:910-917.
7. Bortolotti U, Milano A, Mazzucco A, Guerra F, Estolin L, Thiene G, Gallucci V. Extended follow-up of the standard Hancock porcine bioprosthesis. J Card Surg. 1991;6(suppl):544-549.
8. Atkins CW, Carroll DL, Buckley MJ, Daggett WM, Hilgenberg AD, Austen WG. Late results with Carpentier-Edwards porcine bioprosthesis. Circulation. 1990;82(suppl IV):IV-65-IV-74.
9. Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, Schaf HV, Larsonkeller JJ. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111-1119.
10. Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, Young WG, Oldham HN, Douglas JM, Glower D. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement. Circulation. 1994;90(pt 2):II-214-II-219.
11. Babin-Ebell J, Schmidt W, Eigel P, Elert O. Aortic bioprosthesis without early anticoagulation: risk of thromboembolism. Thorac Cardiovasc Surg. 1995;43:212-214.
12. Davis EA, Greene PS, Cameron DE, Gott VI, Laschinger JC, Stewart RS, Sussman MS, Watkins L, Baumgartner WA. Bioprosthetic vs mechanical prostheses for aortic valve replacement in the elderly. Circulation. 1996; 94(suppl II):II-121-II-125.
13. Pellerin M, Mihaileanue S, Couëtil JP, Relland JYM, Deloche A, Fabiani JN, Jinjani A. Carpentier AF. Carpentier-Edwards pericardial bioprosthesis in the aortic position: long-term follow up 1980-94. Ann Thorac Surg. 1995;60:s292-s296.